Bone Allografts Market Size To Reach $3.0 Billion By 2033

July 2026 | Report Format: Electronic (PDF)

Bone Allografts Market Growth & Trends

The global bone allografts market size is anticipated to reach USD 3.0 billion in 2033 and is projected to grow at a CAGR of 5.3% from 2026 to 2033, according to a new report by Grand View Research, Inc. The rising prevalence of dental problems, ongoing product commercialization, market accessibility & product affordability, rising elderly population, and increasing public awareness regarding preventative care are the major factors driving the demand for dental bone allografts. For instance, about 530 million children experience caries of their primary teeth, according to the World Health Organization (2020), which further estimates that nearly 3.5 billion people are affected by oral disorders. Furthermore, the growing demand for minimally-invasive procedures will also support market growth.

As Minimally Invasive Spine Surgery (MISS) does not require a big incision, it reduces the risk of major injury to the muscles surrounding the spine and allows the surgeon to see only the area of the spine where the problem arises. Due to these approaches, such as using fewer devices, the surgical field (also known as exposure) is smaller, resulting in less pain and a speedier recovery. These factors are expected to drive the overall industry. The industry had a decline in 2020 as a result of the COVID-19 pandemic. All elective surgeries, including spine surgery, were postponed, and the hospitals were transformed into recognized COVID-19 treatment facilities. Such elements consequently hampered the industry expansion.

The expansion of treatment access in many developing countries is likely to increase the demand for healthcare-related products, notably those connected to spinal surgery. The market would expand as a result of the rising demand for these goods, as major developing regions’ economies become more prosperous. Furthermore, due to the temporary shutdown of dental clinics and the fact that all healthcare providers were occupied with COVID-19, dental procedure volumes were substantially decreased. Access was limited to only the most basic care. For instance, the American Dental Association (ADA) advised delaying elective dental surgeries until April 6, 2020, and dental offices should only offer emergency dental care. These factors severely impacted the supply chains of dental bone graft substitute producers.

Thus, these data points suggest that during the COVID-19 pandemic, the demand for dental bone graft alternatives decreased. In dentistry, bone allografts are frequently used. A skilled clinician who can handle and position the allografts in the proper position is required for the preparation and processing for safe use and successful transplant material. The materials’ antigenicity and danger of disease transfer from donor to the recipient are the main issues. Other bone-related operations, from small flaws to significant bone loss following tumor removal, also use bone allografts. Furthermore, the increasing medical and dental tourism sector, burden of dental illnesses, and technical developments in the field of dentistry are also among the key factors contributing to the industry growth.

key Request a free sample copy or view report summary: Bone Allografts Market Report

Bone Allografts Market Report Highlights

The structural allografts segment dominated the bone allografts market in 2025, accounting for the largest revenue share of 40.7%, owing to their proven ability to provide immediate structural support, maintain spinal stability, and achieve high fusion success rates in complex orthopedic procedures.
The spinal fusion segment dominated the bone allografts industry in 2025, accounting for the largest revenue share of 34.2%, driven by the rising incidence of degenerative disc disease, spinal stenosis, scoliosis, and spondylolisthesis, particularly among the growing elderly population.
The hospitals segment dominated the bone allografts market in 2025, accounting for a revenue share of 75.1%. The high share of this segment is due to the availability of most facilities and technologically advanced implants in hospitals for treating and diagnosing spinal disorders.
North America dominated the bone allografts market in 2025, accounting for the largest revenue share of 42.4%. The presence of well-established healthcare infrastructure, supportive reimbursement policies, and widespread adoption of bone grafts in orthopedic surgeries is further fueling the adoption of such products in the region.

Bone Allografts Market Segmentation

Grand View Research, Inc. has segmented the global bone allografts market report based on product, application, end use, and region:

Bone Allografts Product Outlook (Revenue, USD Million/Billion, 2021 - 2033)

Structural Allografts
- Cortical Allografts
- Cancellous Allografts
- Corticocancellous Allografts
- Osteochondral Allografts
- Massive Structural Allografts
Demineralized Bone Matrix (DBM)
- Putty
- Gel
- Paste
- Injectable DBM
- Fibers/Strips/Sheets
Cellular Bone Matrices (CBM)
- Mesenchymal Stem Cell (MSC)-Containing Allografts
- Viable Osteogenic Cell Allografts
- Cryopreserved Cellular Allografts
Machined Allografts
Others (Bone Chips, Bone Powder)